Bayer Monsanto takeover revisited a decade after €55 billion purchase
A new ZEIT podcast episode revisits the Bayer Monsanto takeover, reflecting on Werner Baumann’s €55 billion purchase and the ongoing glyphosate debate.
Werner Baumann’s decision to buy Monsanto ten years ago remains a defining moment for Bayer and for German corporate history. The Bayer Monsanto takeover, completed after a costly bid, is portrayed in a recent episode of ZEIT’s investigative podcast as both a corporate triumph and a high-stakes gamble. Hosts Jens Tönnesmann and Andreas Sentker guide listeners through the acquisition’s origins and the reputational questions that followed. The episode frames the deal as a turning point that continues to shape public and regulatory conversations about agrochemicals.
Baumann’s €55 billion bet
Werner Baumann led the transaction that saw Bayer pay €55 billion to acquire Monsanto, a move that transformed the company’s business profile. At the time, Bayer framed the purchase as a strategic expansion into seeds and crop protection, aiming to create scale and innovation synergies. Critics, however, warned that the takeover combined Bayer’s pharmaceutical and consumer brands with a highly controversial agrochemical portfolio. That tension — between strategic ambition and reputational risk — is central to the podcast’s narrative.
Allegations and imagery invoked during the episode
The ZEIT episode casts Monsanto in stark terms, describing the company with language that underscores public anger and mistrust. Hosts reference portrayals of Monsanto as a symbol of corporate excess and environmental risk, suggesting the takeover was seen by many as a risky marriage between “good and evil.” The program uses interviews and archival material to illustrate how powerful imagery and legal controversies have shaped perceptions of the deal. Listeners hear how those perceptions influenced shareholder debate and public discourse after the acquisition.
Podcast focus on glyphosate’s role
The title of the podcast series explicitly links Bayer’s experience to glyphosate, signaling that the herbicide lies at the heart of the story. The episode explores how glyphosate-related controversies became entangled with Bayer’s corporate identity after the transaction. Producers examine the ways scientific, regulatory and public-relations challenges around the herbicide amplified the stakes of the takeover. The reporting connects those challenges to broader questions about corporate responsibility and product risk management.
Voices behind the episode
Jens Tönnesmann and Andreas Sentker serve as the program’s moderators and lead the investigative reporting throughout the episode. Their reporting blends interviews, reporting, and narration to trace decisions inside Bayer and public reactions outside the company. Production of the episode was handled by Pool Artists, with Joscha Grunewald responsible for sound design. ZEIT names Constanze Kainz and Ole Pflüger as project leads, indicating the publisher’s editorial investment in the series.
Availability and subscription access
ZEIT offers the full series behind a subscription model, with the podcast episode available exclusively to subscribers. The publisher is promoting trial options for listeners interested in accessing the reporting and archives. The episode’s placement behind a paywall follows a broader trend among news organizations to use exclusive audio as a subscriber benefit. ZEIT is positioning the series as both investigative journalism and premium content for subscribers seeking in-depth coverage.
Continuing debate a decade on
A decade after Baumann’s decision, the Bayer Monsanto takeover remains a subject of debate among investors, scientists and civic groups. The podcast underscores how a single corporate decision can produce long-lived financial, legal and reputational consequences. It also highlights the role of investigative audio reporting in revisiting complex corporate episodes and in bringing archival material and expert voices back into public view. For Bayer, the episode is another moment in an ongoing conversation about corporate strategy and societal impact.
Listeners who want to hear the episode will find it as part of the ZEIT series, which includes additional installments examining the acquisition and its aftermath. The reporting combines on-the-record interviews and contextual analysis to trace how the €55 billion transaction reshaped corporate calculation and public debate.
